Patents Assigned to SCOTTSDALE HEALTHCARE
  • Therapeutic targets for adrenocortical carcinoma
    Patent number: 9222138
    Abstract: This invention identifies and provides a recurrent translocation t(4;8) (p16.2; p23.1) associated with Adrenocortical Carcinoma, and diagnostic methods using the translocation by FISH hybridization or PCR based assays.
    Type: Grant
    Filed: October 1, 2012
    Date of Patent: December 29, 2015
    Assignees: THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE, SCOTTSDALE HEALTHCARE CORPORATION
    Inventors: Kimberly Bussey, Michael J. Demeure
  • Methods of assessing a risk of cancer progression
    Patent number: 8911940
    Abstract: Methods and kits that use miRNA expression to predict the development of brain metastases in non-small cell lung cancer patients are disclosed.
    Type: Grant
    Filed: July 29, 2010
    Date of Patent: December 16, 2014
    Assignees: The Translational Genomics Research Institute, Scottsdale Healthcare Corporation
    Inventors: Glen Weiss, Seungchan Kim, Sara Nasser
  • METHODS OF ASSESSING A RISK OF CANCER PROGRESSION
    Publication number: 20120178093
    Abstract: Methods and kits that use miRNA expression to predict the development of brain metastases in non-small cell lung cancer patients are disclosed.
    Type: Application
    Filed: July 29, 2010
    Publication date: July 12, 2012
    Applicants: SCOTTSDALE HEALTHCARE, THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    Inventors: Glen Weiss, Seungchan Kim, Sara Nasser
  • METHODS OF PREDICTING THE RISK OF RECURRENCE OF CANCER
    Publication number: 20120149586
    Abstract: Disclosed herein are methods of predicting the risk of recurrence of cancer on the basis of the expression of microRNA of the miR-520 family.
    Type: Application
    Filed: August 14, 2009
    Publication date: June 14, 2012
    Applicants: SCOTTSDALE HEALTHCARE, THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE
    Inventor: Glen Weiss
  • METHODS AND KITS TO PREDICT PROGNOSTIC AND THERAPEUTIC OUTCOME IN SMALL CELL LUNG CANCER
    Publication number: 20110171323
    Abstract: Disclosed herein are methods used in the identification of cancer patients likely or unlikely to respond to systemic chemotherapy, methods of treating cancer patients based upon the identification, and kits that facilitate the identification. The methods and kits involve detecting the expression of specific microRNA.
    Type: Application
    Filed: January 8, 2011
    Publication date: July 14, 2011
    Applicants: THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE, SCOTTSDALE HEALTHCARE
    Inventor: GLEN J. WEISS